An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover
Nucleic Acids Research · 27.11.2023 · 51 (21) · 11783-11796
DOI: 10.1093/nar/gkad804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.10.2023. Verfasst von Jilin Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Life Science and Technology, Huazhong Agricultural Univer…. Hauptthemen laut MEDLINE: Archaeal Viruses, CRISPR-Cas Systems. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Foundation of Hubei Hongshan Laboratory.
Abstract (Originalsprache)
CRISPR–Cas systems are widespread in prokaryotes and provide adaptive immune against viral infection. Viruses encode a type of proteins called anti-CRISPR to evade the immunity. Here, we identify an archaeal virus-encoded anti-CRISPR protein, AcrIIIB2, that inhibits Type III-B immunity. We find that AcrIIIB2 inhibits Type III-B CRISPR–Cas immunity in vivo regardless of viral early or middle-/late-expressed genes to be targeted. We also demonstrate that AcrIIIB2 interacts with Cmr4α subunit, forming a complex with target RNA and Cmr-α ribonucleoprotein complex (RNP). Furtherly, we discover that AcrIIIB2 inhibits the RNase activity, ssDNase activity and cOA synthesis activity of Cmr-α RNP in vitro under a higher target RNA-to-Cmr-α RNP ratio and has no effect on Cmr-α activities at the target RNA-to-Cmr-α RNP ratio of 1. Our results suggest that once the target RNA is cleaved by Cmr-α RNP, AcrIIIB2 probably inhibits the disassociation of cleaved target RNA, therefore blocking the access of other target RNA substrates. Together, our findings highlight the multiple functions of a novel anti-CRISPR protein on inhibition of the most complicated CRISPR–Cas system targeting the genes involved in the whole life cycle of viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Life Science and Technology, Huazhong Agricultural University, Wuhan 430070, P.R. China.
- Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, 610106, Chengdu, P. R. China.
ORCID-Profile: Nan Peng
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Foundation of Hubei Hongshan Laboratory
- State Key Laboratory of Agricultural Microbiology
Zitieren
APA
Liu, J., Li, Q., Wang, X., Liu, Z., Ye, Q., Liu, T., Pan, S., & Peng, N. (2023). An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover. Nucleic Acids Research, 51(21), 11783-11796. https://doi.org/10.1093/nar/gkad804
Vancouver
Liu J, Li Q, Wang X, Liu Z, Ye Q, Liu T, et al. An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover. Nucleic Acids Research. 2023;51(21):11783-11796. doi:10.1093/nar/gkad804
BibTeX
@article{Liu2023,
author = {Liu, Jilin and Li, Qian and Wang, Xiaojie and Liu, Zhenzhen and Ye, Qing and Liu, Tao and Pan, Saifu and Peng, Nan},
title = {An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover},
journal = {Nucleic Acids Research},
year = {2023},
volume = {51},
number = {21},
pages = {11783--11796},
doi = {10.1093/nar/gkad804}
}
EUVIMED